³í¹®) Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma °Ç±¹´ëº´¿ø ¼Òȱ⳻°ú ±èÁ¤ÇÑ ±³¼ö(»çÁø)